Gene · 406931
Papers2,257
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,257
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expression of Homo Sapiens (Hsa)-miR-139-5p as a Clinically Feasible Prognostic Marker for Differentiated Thyroid Cancer. | Lab Invest | 2025 | 40441300 | PubTator, text mining | PubMed |
| Evaluation of epigenetic silencing of the miR-139-5p gene in the pathogenesis of colorectal cancer and its diagnostic biomarker capability in plasma samples. | BMC Cancer | 2025 | 40375170 | PubTator, text mining | PubMed |
| Exosomes Derived from Metformin-Pretreated BMSCs Accelerate Diabetic Wound Repair by Promoting Angiogenesis Via the LINC-PINT/miR-139-3p/FOXC2 Axis. | Stem Cell Rev Rep | 2025 | 40111729 | PubTator, text mining | PubMed |
| The Combined Impact of Curcumin: Piperine and Sorafenib on microRNAs and Different Pathways in Breast Cancer Cells. | Indian J Clin Biochem | 2025 | 39835241 | PubTator, text mining | PubMed |
| Differential expressions of exosomal miRNAs in patients with chronic heart failure and hyperuricemia: diagnostic values of miR-27a-5p and miR-139-3p. | Nan Fang Yi Ke Da Xue Xue Bao | 2025 | 39819711 | PubTator, text mining | PubMed |
| Extracellular vesicle therapeutics for cardiac repair. | J Mol Cell Cardiol | 2025 | 39603560 | PubTator, text mining | PubMed |
| Exosomal miRNAs in patients with chronic heart failure and hyperuricemia and the underlying mechanisms. | Gene | 2025 | 39241970 | PubTator, text mining | PubMed |
| Shared and specific competing endogenous RNAs network mining in four digestive system tumors. | Comput Struct Biotechnol J | 2024 | 39669749 | PubTator, text mining | PubMed |
| Dystrobrevin beta is a promising prognostic biomarker and therapeutic target for hepatocellular carcinoma. | Am J Transl Res | 2024 | 39544815 | PubTator, text mining | PubMed |
| lncRNA LINC02323 predicts adverse neoadjuvant chemotherapy outcomes of gastric cancer patients and regulates cell sensitivity to 5-fluorouracil by negatively modulating miR-139-3p. | Ann Med | 2024 | 39506605 | PubTator, text mining | PubMed |
| Utility of microRNA analysis in exhaled breath condensate of sarcoidosis and mediastinal tuberculosis patients: a pilot study. | ERJ Open Res | 2024 | 39351385 | PubTator, text mining | PubMed |
| Retraction Note: LncRNA PCAT6 regulates the progression of pituitary adenomas by regulating the miR-139-3p/BRD4 axis. | Cancer Cell Int | 2024 | 38877476 | PubTator, text mining | PubMed |
| Comprehensive analysis of lncRNA-associated ceRNA network reveals novel potential prognostic regulatory axes in glioblastoma multiforme. | J Cell Mol Med | 2024 | 38864705 | PubTator, text mining | PubMed |
| Identifying the differentially expressed peripheral blood microRNAs in psychiatric disorders: a systematic review and meta-analysis. | Front Psychiatry | 2024 | 38827444 | PubTator, text mining | PubMed |
| The EGR1/miR-139/NRF2 axis orchestrates radiosensitivity of non-small-cell lung cancer via ferroptosis. | Cancer Lett | 2024 | 38821254 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts drive colorectal cancer cell progression through exosomal miR-20a-5p-mediated targeting of PTEN and stimulating interleukin-6 production. | BMC Cancer | 2024 | 38561726 | PubTator, text mining | PubMed |
| Long noncoding RNA protein-disulfide isomerase-associated 3 regulated high glucose-induced podocyte apoptosis in diabetic nephropathy through targeting miR-139-3p. | World J Diabetes | 2024 | 38464366 | PubTator, text mining | PubMed |
| Elucidating hepatocellular carcinoma progression: a novel prognostic miRNA-mRNA network and signature analysis. | Sci Rep | 2024 | 38424172 | PubTator, text mining | PubMed |
| Circulating miRNAs and lncRNAs serve as biomarkers for early colorectal cancer diagnosis. | Pathol Res Pract | 2024 | 38377721 | PubTator, text mining | PubMed |
| MicroRNA -21 expression as an auxiliary diagnostic biomarker of acute brucellosis. | Mol Biol Rep | 2024 | 38302783 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406931/papers?page=3